Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Liposome + PTCy Conditioning in Acute Leukemia
NCT05739630Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mitoxantrone-liposome in acute leukemia (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Progression-Free Survival at 2 years. Status: unknown.
02
Drugs
mitoxantrone-liposome
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT05739630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05739630.